Advanced search×

Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease.

Edward V EV Loftus, Scott J SJ Johnson, Si-Tien ST Wang, Eric E Wu, Parvez M PM Mulani, and Jingdong J Chao

Inflamm Bowel Dis 17(1):127-40 (2011) PMID 20848523

Adalimumab is indicated for the treatment of moderately to severely active Crohn's disease (CD). A systematic analysis of risks and benefits of adalimumab versus traditional non-biologic therapies for patients refractory to non-biologic therapy is lacking.

DOI: 10.1002/ibd.21341
Version: za2963e q8za1 q8zb5 q8zc4 q8zd7 q8zed q8zfb q8zg2
Buy PDF

Similar articles you may find interesting…

  1. n-3 fatty acids in patients with multiple cardiovascular risk factors.
    Risk and Prevention Study Collaborative Group, Maria Carla Roncaglioni, and Roberto Marchioli

    N Engl J Med 368(19):1800-8 (2013) PMID 23656645

    We evaluated the potential benefit of such therapy in patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who had not had a myocardial infarction. In this double-blind, placebo-controlled clinical trial, we enrolled a cohort of patients who were fol...
    Buy PDF
  2. Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastat...
    Cuneyt Turkmen, Adem Ucar, and Isik Adalet

    Cancer Biother Radiopharm (2013) PMID 23647219

    Of the 61 patients, 32 were alive at the end of the study; median overall survival (OS) was 17.0±2.5 months (95% confidence interval: 11.9-22.0). A subset analysis of colorectal and noncolorectal groups demonstrated median OS rates of 14.0±5.8 and 17.0±4.8 months, respectively (p=0.543). The mean...
    Buy PDF
  3. In-depth safety-focused analysis of solvents used in electrolytes for large scale lithium ion batteries.
    Gebrekidan Gebresilassie Eshetu, Sylvie Grugeon, and Guy Marlair

    Phys Chem Chem Phys (2013) PMID 23649367

    To better rule out the complex fire risk related to large format lithium ion cells, a detailed and systematic evaluation, both at component and cell levels, could be an invaluable milestone. Therefore, combustion analysis was conducted for major single organic solvents and their mixt...
    Buy PDF